03.14.26 -- Cell & Gene Best Of February

Join Cell & Gene Live Chief Editor Erin Harris on March 19, at 11am Eastern for Materials Matter: Ensuring Quality of CGT Materials. In this live event, experts will explore evolving expectations around material selection, characterization, and sourcing; emerging guidance and standards from USP; how smarter analytics and vendor partnerships can reduce batch failures and CMC setbacks, and more. Register for free thanks to support from our sponsor MilliporeSigma.

In vivo CAR-T is not simply ex vivo without a manufacturing step. It is a different modality that relies on biological systems to regulate outcomes.

From Cell & Gene The Podcast, Dr. Norman Putzki, Novartis, discusses the FDA approval of the only gene replacement therapy approved for children, adolescents, and adults with spinal muscular atrophy (SMA).

Explore a flexible freeze container that maintains package integrity after freezing at -86 °C (-123 °F) through its durable design, minimizing product loss due to package failure.

Learn how to design, normalize, and interpret replicate western blot experiments to ensure reproducible protein quantification with fold change calculations, CV analysis, and visualization strategies.

Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.

Traditional biomanufacturing relies too heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines.